Streptase (Aventis Behringer GmbH) en es it fr

Streptase (Aventis Behringer GmbH) Brand names, Streptase (Aventis Behringer GmbH) Analogs

Streptase (Aventis Behringer GmbH) Brand Names Mixture

  • No information avaliable

Streptase (Aventis Behringer GmbH) Chemical_Formula

C2100H3278N566O669S4

Streptase (Aventis Behringer GmbH) RX_link

http://www.rxlist.com/cgi/generic2/streptokinase.htm

Streptase (Aventis Behringer GmbH) fda sheet

Streptase (Aventis Behringer GmbH) msds (material safety sheet)

Streptase (Aventis Behringer GmbH) Synthesis Reference

No information avaliable

Streptase (Aventis Behringer GmbH) Molecular Weight

47286.7

Streptase (Aventis Behringer GmbH) Melting Point

No information avaliable

Streptase (Aventis Behringer GmbH) H2O Solubility

No information avaliable

Streptase (Aventis Behringer GmbH) State

Liquid

Streptase (Aventis Behringer GmbH) LogP

-0.728

Streptase (Aventis Behringer GmbH) Dosage Forms

Powder for solution; Solution (IV infusion)

Streptase (Aventis Behringer GmbH) Indication

For the treatment of acute evolving transmural myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis or embolism and occlusion of arteriovenous cannulae

Streptase (Aventis Behringer GmbH) Pharmacology

Streptokinase cleaves the Arg/Val bond in plasminogen to form the proteolytic enzyme plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction.

Streptase (Aventis Behringer GmbH) Absorption

No information avaliable

Streptase (Aventis Behringer GmbH) side effects and Toxicity

No information avaliable

Streptase (Aventis Behringer GmbH) Patient Information

No information avaliable

Streptase (Aventis Behringer GmbH) Organisms Affected

Humans and other mammals